These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1259913)

  • 1. Estimation in sera by radioimmunoassay of a specific membrane antigen associated with a murine lymphoma.
    Wolf A; Steele KA; Alexander P
    Br J Cancer; 1976 Feb; 33(2):144-53. PubMed ID: 1259913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of a tumour specific transplantation-type antigen from the ascitic fluid of mice bearing a syngeneic lymphoma.
    Wolf A; Steele KA
    Br J Cancer; 1975 Jun; 31(6):684-8. PubMed ID: 1174446
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity of solubilized tumor antigen extracted from P1798 murine lymphoma cells or isolated from tumor-bearer ascites fluid and reactivity with anti-thy-1.2 antiserum.
    Gordon WC; Baechtel FS; Goetz G; Prager MD
    Int J Cancer; 1977 May; 19(5):692-9. PubMed ID: 68017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytes.
    Dullens HF; Schakenraad S; Oostdijk A; Vuist W; Van der Maas M; Den Otter W
    Cancer Immunol Immunother; 1986; 22(2):100-6. PubMed ID: 3487380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal cell populations during tumour injection.
    De Heer E; De Groot JW; Den Otter W; Dullens HF
    Int J Tissue React; 1982; 4(1):81-90. PubMed ID: 7085002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy with antibody-coated immune and hyperimmune peritoneal cells in a murine lymphoma system.
    Dullens HF; De Weger RA; Woutersen RA; Den Otter W
    J Natl Cancer Inst; 1975 Jan; 54(1):77-82. PubMed ID: 1167595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine natural anti-tumor antibodies. I. Rapid in vivo binding of natural antibody by tumor cells in syngeneic mice.
    Wolosin LB; Greenberg AH
    Int J Cancer; 1979 Apr; 23(4):519-29. PubMed ID: 437926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
    Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strength.
    Fiszer-Maliszewska L; Den Otter W; Mordarski M
    Cancer Immunol Immunother; 1999 Feb; 47(6):307-14. PubMed ID: 10203060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of tumor cells after injection into immunized hosts compared with the eradication of tumor cells after transfer of immune peritoneal exudates into tumor-bearing recipients.
    Den Otter W; De Groot JW; Dullens HF
    Cancer Immunol Immunother; 1983; 16(2):72-6. PubMed ID: 6559103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The destruction of allogeneic tumour cells by antibody and adherent cells from peritoneal cavities of mice.
    Jolley GM; Boyle MD; Ormerod MG
    Cell Immunol; 1976 Mar; 22(2):262-70. PubMed ID: 1277297
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers.
    Thomson DM; Sellens V; Eccles S; Alexander P
    Br J Cancer; 1973 Nov; 28(5):377-88. PubMed ID: 4758368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibody responses to an ascitic variant of rat hepatoma D23.
    Robins RA
    Br J Cancer; 1975 Jul; 32(1):21-7. PubMed ID: 169868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of tumour-specific membrane antigen in the serum of rats with chemically induced sarcomata.
    Thomson DM; Steele K; Alexander P
    Br J Cancer; 1973 Jan; 27(1):27-34. PubMed ID: 4568460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.
    Manson LA
    Cancer Detect Prev Suppl; 1987; 1():111-20. PubMed ID: 3121177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice.
    De Weger RA; Wilbrink B; Moberts RM; Mans D; Oskam R; Den Otter W
    Cancer Immunol Immunother; 1987; 24(1):25-36. PubMed ID: 3493070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
    Biddison WE; Palmer JC
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):329-33. PubMed ID: 402006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenicity and immunogenicity associated with membranes isolated from cell-free ascites fluid of lymphoma-bearing mice.
    Raz A; Barzilai R; Spira G; Inbar M
    Cancer Res; 1978 Aug; 38(8):2480-5. PubMed ID: 667843
    [No Abstract]   [Full Text] [Related]  

  • 19. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface antigen expression on chemically induced murine leukaemias.
    Birch JM; Moore M; Craig AW
    Br J Cancer; 1975 Jun; 31(6):630-40. PubMed ID: 1174442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.